03/26/2025
6:00 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
6:08 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
7:00 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
7:03 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
8:34 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
8:36 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
6:57 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
03/10/2025
5:46 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
5:44 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
5:45 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
7:56 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for GMTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/27/2025
7:17 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
7:11 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
6:27 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:29 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:31 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Yu Jonathan Yen-Wen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:33 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:36 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Khara Rahul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:38 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Stephenson Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
6:50 AM | Bain Capital Life Sciences Opportunities III, LP (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
5:43 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Khara Rahul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:48 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Stephenson Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:33 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:35 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:38 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Franchi Jean M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
5:40 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Yu Jonathan Yen-Wen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:08 AM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
02/10/2025
9:25 AM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
3:28 PM | Atlas Venture Fund X, L.P. (Reporting)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
4:24 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 424B5 | |
01/21/2025
4:24 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 424B5 | |
01/21/2025
6:52 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:04 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
4:56 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Khara Rahul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
6:13 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:20 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Khara Rahul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/30/2024
3:11 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Quisel John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
4:18 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:21 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Quisel John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
6:41 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:39 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Quisel John D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Warning: “DOGE Collapse” imminent (Ad) Elon Strikes Back
You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead. Click here to see what they’re predicting now. |
12/09/2024
7:48 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:03 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:46 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Savage William Jacob (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
11:15 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form EFFECT | |
11/19/2024
5:46 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:31 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:44 PM | Bain Capital Life Sciences Opportunities III, LP (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024
3:33 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/08/2024
7:49 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
6:16 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
6:55 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
12:11 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
| Form SC 13G | |
10/03/2024
3:29 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:05 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:39 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Savage William Jacob (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
3:06 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:23 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form S-3ASR | |
08/08/2024
7:06 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:15 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
4:10 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
White William Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
3:15 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Quisel John D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
9:06 AM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SC 13G | |
06/20/2024
7:00 PM | Bitterman Kevin (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:27 PM | Ashiya Mona (Reporting)
Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:19 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:15 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
06/14/2024
6:36 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:15 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
7:07 AM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
3:05 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
5:27 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
4:02 PM | Gemini Therapeutics (Issuer)
Disc Medicine, Inc. (Issuer)
Savage William Jacob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
3:14 PM | Gemini Therapeutics (Subject)
Disc Medicine, Inc. (Subject)
White William Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
4:25 PM | Gemini Therapeutics (Filer)
Disc Medicine, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
